SAC Capital Advisors LP is seeking to calm investor concern about founder Steven A. Cohenís trading in two drug stocks and possible regulatory sanctions after prosecutors for the first time tied Cohen to a specific transaction at the center of an insider-trading investigation.
Cohen’s SAC Faces Client Questions as U.S. Investigators Circle
To continue, please sign in or become a member.
Join the On Wall Street
MEMBERSHIP IS FREE
- Access to essential information that independent advisors need to make informed decisions
- Exclusive E-Newsletters delivering the latest headlines to your inbox
- Access to white papers, web seminars, blogs, discussion boards, and CE exams
Have an account?
SIGN IN HERE